Viatris Inc Total Assets
Viatris Inc total assets. Based on the latest financial reports, Viatris Inc (VTRS) holds total assets worth $35.04 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Viatris Inc for the company's overall valuation and market capitalisation.
Total Assets of Viatris Inc (1985–2025)
Total assets of Viatris Inc from 1985 to 2025. This chart illustrates how Viatris Inc's total assets have evolved over time, based on quarterly financial data. See VTRS live share price for real-time trading data and today's change.
Viatris Inc - Asset Composition Analysis
Viatris Inc Total Assets Breakdown (December 2025)
Viatris Inc total assets breakdown as of December 2025. Viatris Inc's total assets of $35.04 Billion consist of 24.8% current assets and 75.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.6% |
| Accounts Receivable | $3.35 Billion | 9.0% |
| Inventory | $4.00 Billion | 10.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.10 Billion | 40.6% |
| Goodwill | $6.75 Billion | 18.2% |
Asset Composition Trend (1985–2025)
This chart illustrates how Viatris Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore VTRS current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Viatris Inc's current assets represent 24.8% of total assets in 2025, a decrease from 79.5% in 1985.
- Cash Position: Cash and equivalents constituted 3.6% of total assets in 2025, down from 26.8% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is intangible assets at 40.6% of total assets.
Viatris Inc Competitors by Total Assets
Key competitors of Viatris Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Viatris Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.58 | 1.37 | 1.12 |
| Quick Ratio | 0.96 | 0.77 | 0.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.71 Billion | $2.64 Billion | $1.20 Billion |
Viatris Inc - Advanced Valuation Insights
This section examines the relationship between Viatris Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.31 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | -10.4% |
| Total Assets | $37.19 Billion |
| Market Capitalization | $18.70 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Viatris Inc's assets below their book value (0.50x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Viatris Inc's assets decreased by 10.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Viatris Inc (1985–2025)
The table below shows the annual total assets of Viatris Inc from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $37.19 Billion | -10.38% |
| 2024-12-31 | $41.50 Billion | -12.97% |
| 2023-12-31 | $47.69 Billion | -4.67% |
| 2022-12-31 | $50.02 Billion | -8.79% |
| 2021-12-31 | $54.84 Billion | -10.90% |
| 2020-12-31 | $61.55 Billion | +96.93% |
| 2019-12-31 | $31.26 Billion | -4.52% |
| 2018-12-31 | $32.73 Billion | -8.58% |
| 2017-12-31 | $35.81 Billion | +3.11% |
| 2016-12-31 | $34.73 Billion | +55.95% |
| 2015-12-31 | $22.27 Billion | +40.75% |
| 2014-12-31 | $15.82 Billion | +3.44% |
| 2013-12-31 | $15.29 Billion | +28.18% |
| 2012-12-31 | $11.93 Billion | +2.88% |
| 2011-12-31 | $11.60 Billion | +0.53% |
| 2010-12-31 | $11.54 Billion | +6.81% |
| 2009-12-31 | $10.80 Billion | +3.93% |
| 2008-12-31 | $10.39 Billion | -8.45% |
| 2007-12-31 | $11.35 Billion | +166.89% |
| 2006-12-31 | $4.25 Billion | +127.42% |
| 2005-12-31 | $1.87 Billion | -12.42% |
| 2004-12-31 | $2.14 Billion | +13.29% |
| 2003-12-31 | $1.89 Billion | +8.01% |
| 2002-12-31 | $1.75 Billion | +7.95% |
| 2001-12-31 | $1.62 Billion | +10.28% |
| 2000-12-31 | $1.47 Billion | +9.30% |
| 1999-12-31 | $1.34 Billion | +11.15% |
| 1998-12-31 | $1.21 Billion | +42.33% |
| 1997-12-31 | $847.80 Million | +9.03% |
| 1996-12-31 | $777.60 Million | +12.37% |
| 1995-12-31 | $692.00 Million | +26.69% |
| 1994-12-31 | $546.20 Million | +35.43% |
| 1993-12-31 | $403.30 Million | +14.87% |
| 1992-12-31 | $351.10 Million | +54.87% |
| 1991-12-31 | $226.70 Million | +33.67% |
| 1990-12-31 | $169.60 Million | +23.35% |
| 1989-12-31 | $137.50 Million | +22.01% |
| 1988-12-31 | $112.70 Million | +3.58% |
| 1987-12-31 | $108.80 Million | +35.49% |
| 1986-12-31 | $80.30 Million | +43.39% |
| 1985-12-31 | $56.00 Million | -- |
About Viatris Inc
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and … Read more